this drug is used on drug eluting stents to help prevent restinosis, so it is getting used (fairly extensively) regardless of the UK.
The use of drugs like this one on stents is a different issue...MUCH smaller amount of the drug used to coat a stent, but more important, the clinical development that Novartis had to invest in for the cancer indication has nothing whatsoever to do with the cardiac indication. Apples to Buicks.